NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-24-105 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-095 from the NIH Guide for Grants and Contracts
Notice NOT-CA-24-039 from the NIH Guide for Grants and Contracts
Notice NOT-AT-24-040 from the NIH Guide for Grants and Contracts
Notice NOT-HG-24-031 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-018 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-203 from the NIH Guide for Grants and Contracts. This NOFO will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following: - Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is already present (for example, in a model of AD/ADRD). - Mechanistic studies that address how COVID-19 accelerates AD/ADRD pathology and cognitive deficits in a prodromal model (early phase, pre-symptomatic). - Mechanistic studies that address how COVID-19 predisposes for AD/ADRD and/or interacts with relevant comorbid conditions and risk factors (cellular mechanisms that could potentially increase the risk for future AD/ADRD).
Funding Opportunity PAR-24-139 from the NIH Guide for Grants and Contracts. To support outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences, over the transition from predoctoral to postdoctoral research training.. This phased award program will facilitate completion of graduate PhD or dual degree clinician scientist programs (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00).
Notice NOT-MH-24-225 from the NIH Guide for Grants and Contracts
Notice NOT-NS-24-068 from the NIH Guide for Grants and Contracts
Notice NOT-MD-24-012 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-022 from the NIH Guide for Grants and Contracts
Notice NOT-HD-24-021 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-099 from the NIH Guide for Grants and Contracts
Notice NOT-HL-24-012 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-097 from the NIH Guide for Grants and Contracts
Notice NOT-EY-24-004 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-168 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to reissue PAR-24-256 "Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)" in order to support proof-of-concept feasibility trials guided by the NIH Music-based Interventions (MBI) Toolkit for research on brain disorders of aging. These early stage clinical trials will generate evidence supporting the validity of the NIH MBI Toolkits guiding principles as well as the necessary pilot data to assess the feasibility of the design for a subsequent clinical efficacy or effectiveness study (or pragmatic clinical trial) using music-based interventions in the context of brain disorders of aging, including but not limited to Alzheimers disease and Alzheimers disease-related dementias, Parkinsons disease, and stroke. The data collected should address gaps in scientific knowledge in order to facilitate development of a competitive large-scale clinical trial.
Funding Opportunity PAR-24-198 from the NIH Guide for Grants and Contracts. This initiative is designed to promote discovery of cellular and molecular mechanisms that underlie brain blood vessels responses to passive anti-beta-amyloid immunotherapy that result in amyloid-related imaging abnormalities (ARIA). The goal is to establish an understanding of molecular mechanisms that can be targeted to protect the blood brain barrier (BBB), and thus the brain blood vessels, during therapeutic interventions that target beta-amyloid.
Funding Opportunity PAR-24-166 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.